Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type
NCT ID: NCT00036114
Last Updated: 2013-11-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
INTERVENTIONAL
2000-03-31
2003-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
TREATMENT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
aripiprazole
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
55 Years
95 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Otsuka Pharmaceutical Development & Commercialization, Inc.
INDUSTRY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Local Institution
Tuscaloosa, Alabama, United States
Local Institution
Scottsdale, Arizona, United States
Local Institution
Cerritos, California, United States
Local Institution
Granada Hills, California, United States
Local Institution
Los Angeles, California, United States
Local Institution
San Diego, California, United States
Local Institution
Torrance, California, United States
Local Institution
Denver, Colorado, United States
Local Institution
Hamden, Connecticut, United States
Local Institution
Miami, Florida, United States
Local Institution
North Miami Beach, Florida, United States
Local Institution
West Palm Beach, Florida, United States
Local Institution
Atlanta, Georgia, United States
Local Institution
Augusta, Georgia, United States
Local Institution
Macon, Georgia, United States
Local Institution
Honolulu, Hawaii, United States
Local Institution
North Chicago, Illinois, United States
Local Institution
Springfield, Illinois, United States
Local Institution
New Orleans, Louisiana, United States
Local Institution
Shreveport, Louisiana, United States
Local Institution
Baltimore, Maryland, United States
Local Institution
Newton Center, Massachusetts, United States
Local Institution
Springfield, Massachusetts, United States
Local Institution
Wellesley Hills, Massachusetts, United States
Local Institution
Lyons, New Jersey, United States
Local Institution
Albany, New York, United States
Local Institution
Lawrence, New York, United States
Local Institution
Montrose, New York, United States
Local Institution
Northport, New York, United States
Local Institution
White Plains, New York, United States
Local Institution
Raleigh, North Carolina, United States
Local Institution
Beachwood, Ohio, United States
Local Institution
Portland, Oregon, United States
Local Institution
Hershey, Pennsylvania, United States
Local Institution
Austin, Texas, United States
Local Institution
Dallas, Texas, United States
Local Institution
San Antonio, Texas, United States
Local Institution
Wichita Falls, Texas, United States
Local Institution
Bennington, Vermont, United States
Local Institution
Charlottesville, Virginia, United States
Local Institution
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Muhlbauer V, Mohler R, Dichter MN, Zuidema SU, Kopke S, Luijendijk HJ. Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia. Cochrane Database Syst Rev. 2021 Dec 17;12(12):CD013304. doi: 10.1002/14651858.CD013304.pub2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CN138-004
Identifier Type: -
Identifier Source: org_study_id